OMNISCAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Omniscan, and when can generic versions of Omniscan launch?
Omniscan is a drug marketed by Ge Healthcare and is included in two NDAs.
The generic ingredient in OMNISCAN is gadodiamide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadodiamide profile page.
Summary for OMNISCAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 6 |
Patent Applications: | 1,341 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OMNISCAN |
What excipients (inactive ingredients) are in OMNISCAN? | OMNISCAN excipients list |
DailyMed Link: | OMNISCAN at DailyMed |
Recent Clinical Trials for OMNISCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bayer AG (Sponsor) | Phase 4 |
GEHC (Sponsor) | Phase 4 |
Guerbet | Phase 4 |
Pharmacology for OMNISCAN
Drug Class | Paramagnetic Contrast Agent |
Mechanism of Action | Magnetic Resonance Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for OMNISCAN
US Patents and Regulatory Information for OMNISCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-001 | Sep 5, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-002 | Sep 5, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 020123-001 | Jan 8, 1993 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OMNISCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 020123-001 | Jan 8, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-002 | Sep 5, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-001 | Sep 5, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 020123-001 | Jan 8, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 020123-001 | Jan 8, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OMNISCAN
See the table below for patents covering OMNISCAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 601916 | ⤷ Try a Trial | |
Austria | 52247 | ⤷ Try a Trial | |
New Zealand | 219079 | METAL COMPLEX SALTS AND DIAGNOSTIC PREPARATIONS FOR USE IN NMR DIAGNOSIS | ⤷ Try a Trial |
Japan | H0768193 | ⤷ Try a Trial | |
Germany | 3448606 | Diagnostische Mittel, Verfahren zu deren Herstellung und deren Verwendung | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OMNISCAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0071564 | SPC/GB93/060 | United Kingdom | ⤷ Try a Trial | |
0216511 | 94C0015 | Belgium | ⤷ Try a Trial | PRODUCT NAME: GADODIAMIDE; NAT. REGISTRATION NO/DATE: NL 19253 19940425; FIRST REGISTRATION: GB - 0637/0015 19920925 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |